Industry to Biden: Count Us In On Cancer Moonshot

AdvaMed says the medtech industry needs to at the table to advise the government on investments that could lead to future cancer diagnostics and treatments.

President Joe Biden tours the radiation oncology department at the Arthur James Cancer Hospital in Columbus, OH, on 23 March, 2021
President Joe Biden tours the radiation oncology department at the Arthur James Cancer Hospital in Columbus, OH, on 23 March, 2021 • Source: Alamy

Following US President Joe Biden’s decision to relaunch the Cancer Moonshot project, medtech lobby group AdvaMed said the device and diagnostics industry should be included in conversations to advance cancer research.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Medtech Insight

Execs On The Move: 24-28 March 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Roar Of Eargo-hearX Merger Echoes Through US OTC Hearing Aid Market

 

The firms recently announced they will operate as combined company LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands. Eargo majority owner Patient Square Capital added $100m to its investment.

Birmingham City University Develops New Defense Mechanism Against Cyberattacks On AI Systems

 

AI systems used in healthcare are vulnerable to adversarial cyberattacks, which are a growing concern, said Atif Azad, a professor of AI at Birmingham City University. Azad’s research group has developed a method that trains AI to become more resilient to cyber threats through the use of random image adjustments.